At the time of writing, Silk Road Medical Inc [SILK] stock is trading at $27.08, up 0.11%. Until recently, the best way to gauge how the stock has performed was to look at its short-term value. The SILK shares have lost -0.04% over the last week, with a monthly amount glided 0.67%, and seem to be holding up well over a long-time horizon.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
From an analyst’s perspective:
Silk Road Medical Inc [NASDAQ: SILK] stock has seen the most recent analyst activity on July 11, 2024, when Argus downgraded its rating to a Sell. Previously, Argus upgraded its rating to Buy on March 07, 2024, and kept the price target unchanged to $24. On January 19, 2024, upgrade upgraded it’s rating to Buy and revised its price target to $20 on the stock. Lake Street started tracking the stock assigning a Buy rating and suggested a price target of $20 on January 03, 2024. Wolfe Research upgraded its rating to a Peer Perform. Stifel downgraded its rating to Hold for this stock on October 11, 2023, and downed its price target to $12. In a note dated October 11, 2023, CL King downgraded an Neutral rating on this stock.
For the past year, the stock price of Silk Road Medical Inc fluctuated between $6.08 and $27.19. Currently, Wall Street analysts expect the stock to reach $30.58 within the next 12 months. Silk Road Medical Inc [NASDAQ: SILK] shares were valued at $27.08 at the most recent close of the market. An investor can expect a potential return of 12.92% based on the average SILK price forecast.
Analyzing the SILK fundamentals
According to Silk Road Medical Inc [NASDAQ:SILK], the company’s sales were 185.49M for trailing twelve months, which represents an 20.81% jump. Gross Profit Margin for this corporation currently stands at 0.73% with Operating Profit Margin at -0.31%, Pretax Profit Margin comes in at -0.29%, and Net Profit Margin reading is -0.29%. To continue investigating profitability, this company’s Return on Assets is posted at -0.21, Equity is -0.35 and Total Capital is -0.25. An extended analysis of the company’s primary financial structure reveals a debt-to-equity ratio of0.53.
Before buying any particular stock, readers tend to pay close attention to the indicators that support and create resistance. The company’s stock is currently sitting at 27.04 points at the first support level, and at 26.99 for the second support level. However, for the 1st resistance point, the stock is sitting at 27.12, and for the 2nd resistance point, it is at 27.15.
Ratios To Look Out For
It is important to note that Silk Road Medical Inc [NASDAQ:SILK] has a current ratio of 11.05. As well, the Quick Ratio is 9.62, while the Cash Ratio is 1.06. Considering the valuation of this stock, the price to sales ratio is 5.93, the price to book ratio is 7.25.
Transactions by insiders
Recent insider trading involved Davis Andrew S., Chief Commercial Officer, that happened on Jul 03 ’24 when 66.0 shares were sold. Director, Ballinger Kevin J. completed a deal on Mar 05 ’24 to buy 11700.0 shares. Meanwhile, COO/CFO Buchanan Lucas W. sold 9877.0 shares on Mar 05 ’24.
